Volex has delivered a strong share price run in recent years, and the question now is whether that move is supported by the cash the business can generate. With the stock pulling back over the past week after a much longer climb, the current valuation comes down to how those cash flows stack up against today's price.
-
Over the past 3 years the share price has gained 135.7%, which puts real weight on whether the underlying cash generation is strong enough to underpin that kind of performance.
-
The group relies on turning its operating profits into steady free cash flow, which can support reinvestment in the business and help limit how much fresh capital it may need from shareholders.
-
Prefer to judge Volex on earnings? See why Volex's 23.8x P/E tells a different valuation story .
The issue now is whether Volex's recent share price level is justified by the cash flows implied by a Discounted Cash Flow (DCF) intrinsic value estimate.
To see how Volex compares with other companies where valuation hinges on cash generation, put it alongside the 7 high quality undervalued stocks
Is Volex Getting Expensive on Cash Flow?
The Discounted Cash Flow (DCF) model here is built around the cash Volex can return to shareholders over time. On the latest figures the group produced trailing twelve month free cash flow of about US$26.7 million, which gives the valuation a concrete starting point rather than a story built only on revenue or earnings.
The 2 Stage Free Cash Flow to Equity model then leans on a path of growing free cash flows, with analyst forecasts feeding into the near years and more moderate estimates beyond that. When those projected US$ cash flows are discounted back and compared with the current £6.37 share price, the DCF points to an estimated intrinsic value that sits substantially below where the stock now trades. That gap suggests the current market is already pricing in a healthy level of future delivery from Volex, so the interest for you is whether the cash generation profile in the model feels robust enough to support that optimism. Find out what Volex could be worth using our Discounted Cash Flow (DCF) estimate .
The Volex Narrative: What Would Justify Today's Price?
Volex's valuation puzzle sets up the role of Simply Wall St Narratives, which spell out the specific paths for growth, margins and earnings that would need to play out for the stock to be worth materially more or less than today's price and sit on the Community page for the company. Each narrative ties a valuation number to a clear view on where growth, profitability and key risks could head next. This gives you a reference point to revisit as new information emerges.
One of the top community narratives on Volex: 21% undervalued
"Bullish analysts highlight the Kepler SignalTek acquisition as a key support for the medical segment, particularly in patient connected products…"
Discover why this Narrative puts Volex at 21% undervalued .
An unanswered question for Volex, who is steering the ship and on what terms
Cash flows tell part of the Volex story, but you still need to understand who is calling the shots, how their incentives are structured, and whether that lines up with your interests. See who runs Volex and how they are paid .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include VLX.L .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com









